Postprandial lipemia--effect of lipid-lowering drugs (Q34666856)

3 August 2017

1 reference

title

Postprandial lipemia--effect of lipid-lowering drugs (English)

1 reference

3 August 2017

1 reference

Fredrik Karpe

1

0 references

publication date

1 May 2002

1 reference

Atherosclerosis. Supplements

3 August 2017

1 reference

3 August 2017

3

1 reference

3 August 2017

1

1 reference

3 August 2017

41-46

1 reference

Postprandial lipoprotein metabolism and atherosclerosis.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Atherogenesis: a postprandial phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Postprandial lipemia, fenofibrate and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Postprandial vitamin A and squalene clearances and cholesterol synthesis off and on lovastatin treatment in type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Orlistat fails to alter postprandial plasma lipid excursions or plasma lipases in normal-weight male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Activation of coagulation factor VII during alimentary lipemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-beta levels

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Effect of a single high-fat meal on endothelial function in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

The postprandial effect of components of the Mediterranean diet on endothelial function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Enhanced peripheral vasodilation in humans after a fatty meal

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Resistance vessel endothelial function in healthy humans during transient postprandial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Influence of Folic Acid on Postprandial Endothelial Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

The adipocyte, fatty acid trapping, and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

Postprandial triglyceride response in visceral obesity in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900004-6

7 January 2021

10.1016/S1567-5688(01)00004-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12044585